[1]付 莹,吕金鹏,李文建,等.血脑屏障渗透模型PAMPA的构建及其条件优化[J].常州大学学报(自然科学版),2019,31(04):86-92.[doi:10.3969/j.issn.2095-0411.2019.04.012]
　FU Ying,LYU Jinpeng,LI Wenjian,et al.Model Establishment and Optimized Conditions of PAMPA for Blood-Brain Barrier[J].Journal of Changzhou University(Natural Science Edition),2019,31(04):86-92.[doi:10.3969/j.issn.2095-0411.2019.04.012]
点击复制

血脑屏障渗透模型PAMPA的构建及其条件优化()
分享到：

常州大学学报(自然科学版)[ISSN:2095-0411/CN:32-1822/N]

卷:
第31卷
期数:
2019年04期
页码:
86-92
栏目:
生物医学工程
出版日期:
2019-07-28

文章信息/Info

Title:
Model Establishment and Optimized Conditions of PAMPA for Blood-Brain Barrier
文章编号:
2095-0411(2019)04-0086-07
作者:
付 莹; 吕金鹏; 李文建; 丁淑敏; 柳 丽; 宋国强
(常州大学 制药与生命科学学院,江苏 常州 213164)
Author(s):
FU Ying; LYU Jinpeng; LI Wenjian; DING Shumin; LIU Li; SONG Guoqiang
(School of Pharmaceutical Engineering & Life Sciences, Changzhou University, Changzhou 213164, China)
关键词:
平行人工膜渗透模型;  血脑屏障;  助溶剂;  磷脂膜;  渗透率
Keywords:
parallel artificial membrane permeation model;  Blood-Brain Barrier;  cosolvent;  phospholipid film;  permeability
分类号:
TK 8
DOI:
10.3969/j.issn.2095-0411.2019.04.012
文献标志码:
A
摘要:
平行人工膜渗透模型(parallel artificial membrane permeation assay,PAMPA)主要以人工磷脂作为生物膜来模拟药物跨膜的屏障,能测定通过被动扩散途径跨过血脑屏障的药物,该模型操作简单,成本低。以实验室合成的化合物为研究对象,在MultiScreen 96-well板上铺一层牛脑磷脂的十二烷溶液作为PAMPA模型,并通过高效液相色谱(HPLC)测定化合物的血脑屏障渗透率。实验中发现亲脂性化合物水溶性较差,需要添加助溶剂以帮助溶解,因此考察了4种助溶剂(DMSO、乙腈、乙醇、正丙醇)对化合物溶解度的影响及助溶剂含量对磷脂膜完整性的影响,最终选择了浓度为10% 的正丙醇做为助溶剂来进行渗透实验,测得了各个化合物的渗透率,并筛选出了渗透率最好的化合物,为将来的药物开发提供指导。
Abstract:
Parallel artificial membrane permeation assay(PAMPA)mainly uses artificial phospholipids as biofilm to simulate the barrier of drug transmembrane, and can measure drugs that cross the blood-brain barrier through passive diffusion. The model is simple in operation and low in cost. In this study, a laboratory-synthesized compound was used as a research object. A layer of bovine brain phospholipid dodecane solution was applied to the MultiScreen 96-well plate as a PAMPA model, and the Blood-Brain Barrier Permeability of the compound was determined by high performance liquid chromatography(HPLC). In the experiment, it was found that the lipophilic of four cosolvents(DMSO, acetonitrile, ethanol, n-propanol)on the solubility of the compound and compound was poorly water-soluble. To solve this problem, this experiment investigated the effects of the concentration of the cosolvent on the integrity of the phospholipid membrane. The effect was chosen to select the best cosolvent for the penetration test of the Blood-Brain Barrier penetration model PAMPA.

参考文献/References:

[1] EGLETON R D, DAVIS T P. Bioavailability and transport of peptides and peptide drugs into the Brain-Binding to plasma proteins[J]. Peptides, 1997, 18(9): 1431-1439.
[2]PARDRIDGE W M. CNS drug design based on principles of Blood-Brain Barrier transport[J]. Neuro Chem, 1998, 70(5): 1781-1792.
[3]SCHERRMANN J M. Drug delivery to brain via the Blood-Brain Barrier[J]. Vascular Pharmacology, 2002, 38(6): 349-354.
[4]SUN J, XIE L, LIU X. Transport of carbamazepine and drug interactions at Blood-Brain Barrier[J]. Acta Pharmacol Sin, 2006, 27(2): 249-253.
[5]MAYUR M P, BHOOMIKA M P. Crossing the Blood-Brain Barrier: recent advances in drug delivery to the brain[J]. CNS Drugs, 2017, 31(2): 109-133.
[6]艾妮.中药成分血脑屏障渗透性的计算预测研究及验证[D]. 杭州: 浙江大学, 2017.
[7]粱超, 李安民. 评价药物通过血脑屏障方法现状[J]. 临床军医杂志, 2009, 37(3): 498-500.
[8]HABGOOD M D, BEGLEY D J, ABBOTT N J. Determinants of passive drug entry into the central nervous system[J]. Cell Mol Neurobiol, 2000, 20(2): 231-252.
[9]KANSY M, SENNER F, GUBERNATOR K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes[J]. Journal of Medicinal Chemistry, 1998, 41(7): 1007-1010.
[10]MALAKOUTIKHAH M, PRADES R, TEIXIDO M, et al. N-Methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles[J]. J Med Chem, 2010, 53(6): 2354-2363.
[11]于晖.合成磷脂类化合物及其药物[D].上海: 东华大学,2009: 80-100.
[12]葛建丹, 陈媚, 宋必卫. 用PAMPA和MDCK模型研究川芎嗪的跨膜吸收机制[J]. 浙江工业大学学报, 2010, 38(6): 616-619.
[13]SUGANO K, HAMADA H, MACHIDA M, et al. High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay[J]. J Biomol Screen, 2001, 6(3): 189-196.
[14]吴一凡, 刘晖, 倪京满. 平行人工膜渗透模型及其应用进展[J]. 药学学报, 2011, 46(8): 890-895.
[15]MORTEZA M, MERITXELL T, ERNEST G. Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries[J]. J Med Chem, 2008, 51(16): 4881-4889.
[16]KIYOHIKO S, HIROKAZU, MINORU M, et al. Optimized conditions of bio-mimetic artificial membrane permeation assay[J]. International Journal of Pharmaceutics, 2001, 228(2): 181-188.
[17]颜锐思, 张晓露, 杨慧, 等. 药物平行人工膜渗透性试验的研究进展[J]. 今日药学, 2012, 22(1): 51-55.
[18]LIPINSKI C A. Drug-like property and the cause of poor solubility and poor permeability[J]. J Pharm Toxicol Meth, 2000, 44(1): 235-249.
[19]马林楠, 刘晖, 倪京满. 血脑屏障渗透模型PAMPA的构建及其应用[J]. 中国科技论文在线, 2014, 7(11): 1093-1096.
[20]LI D, EDWARD H K, KRISTI F, et al. High throughput artificial membrane permeability assay for Blood-Brain Barrier[J]. European Journal of Medicinal Chemistry, 2003, 38(3): 223-232.

备注/Memo

备注/Memo:
收稿日期:2018-03-20。
基金项目:国家自然科学基金资助项目(81603336)。
作者简介:付莹(1993—),女,江苏徐州人,硕士生。通信联系人:宋国强(1969—),E-mail:sgq@cczu.edu.cn
更新日期/Last Update: 2019-07-16